Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices

References

• Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies—tacking the opioid-overdose epidemic. N Engl J Med. 2014;370:2063–2066.
   PubMed Web of Science ®Google Scholar
• Global Commission on Drug Policy. Taking Control: Pathways to Drug Policies that Work. Available at: http://static1.squarespace.com/static/53ecb452e4b02047c0779e59/t/540da6ebe4b068678cd46df9/1410180843424/global_commission_EN.pdf. Published 2014. Accessed October 22, 2015.
   Google Scholar
• Herberman, EJ, Bonczar, TP. Probation and Parole in the United States, 2013. The U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. NCJ 248029 October 2014 (revised January 21, 2015), http://www.bjs.gov/content/pub/pdf/ppus13.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The NSDUH Report: Trends in Substance Use Disorders among Males Aged 18 to 49 on Probation or Parole, March 6, 2014. Rockville, MD. Available at: http://www.samhsa.gov/data/sites/default/files/sr084-males-probation-parole/sr084-males-probation-parole/sr084-males-probation-parole.htm
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone Maintenance Therapy Versus No Opioid Replacement Therapy for Opioid Dependence (Review). Cochrane Database Syst Rev. 2009(3).
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews. 2014; 2. Art. No.: CD002207. doi:10.1002/14651858.CD002207.pub4
   Google Scholar
• Institute of Medicine. Improving the Quality for Health Care and Mental Health and Substance Use Conditions. Washington, DC: National Academies Press; 2006.
   Google Scholar
• National Institutes of Health. Effective medical treatment of opiate addiction. JAMA. 1997;280:1936–1943.
   Web of Science ®Google Scholar
• World Health Organization. Status Paper on Prisons, Drugs and Harm Reduction. Copenhagen, Denmark: World Health Organization; 2005.
   Google Scholar
• Clark CB, Hendricks PS, Lane PS, Trent L, Cropsey KL. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community supervision. Addict Behav. 2014;39:1736–1740.
   PubMed Web of Science ®Google Scholar
• Gordon MS, Kinlock TW, Schwartz RP, et al. Buprenorphine treatment for probationers and parolees. Subst Abus. 2015;36:217–225.
   PubMed Web of Science ®Google Scholar
• Gryczynski J, Kinlock TW, Kelly SM, O'Grady KE, Gordon MS, Schwartz RP. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, crime. Subst Abus. 2012;33:30–39.
   PubMed Web of Science ®Google Scholar
• Anglin MD. The efficacy of civil commitment in treating narcotic addiction. J Drug Issues. 1988;18:527–545.
   Web of Science ®Google Scholar
• Kelly SM, O'Grady KE, Jaffe JH, Gandhi D, Schwartz RP. Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment. J Addict Med. 2013;7:133–138.
   PubMed Web of Science ®Google Scholar
• Mitchell SG, Gryczynski J, Kelly SM, et al. Treatment outcomes of African American buprenorphine patients by parole and probation status. J Drug Issues. 2014;44:69–82.
   PubMed Web of Science ®Google Scholar
• Friedmann PD, Ducharme LJ, Welsh W, et al. A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol. Health Justice. 2013;1:6
   Google Scholar
• Friedmann PD, Wilson D, Knudsen H, et al. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. J Subst Abuse Treat. 2015;50:50–58.
   PubMed Web of Science ®Google Scholar
• Lee JD, Rich JD. Opioid pharmacotherapy in criminal justice settings: now is the time. Subst Abus. 2012;33:1–4.
   PubMed Web of Science ®Google Scholar
• Randolph F, Blasinsky M, Morrissey JP, et al. Overview of the ACCESS Program. Access to community care and effective services and supports. Psychiatr Serv. 2002;53:945–948.
   PubMed Web of Science ®Google Scholar
• Muhr T, Friese S. User's manual for ATLAS.ti 5.0. 2nd ed. Berlin, Germany: Scientific Software Development; 2000.
   Google Scholar
• Strauss A, Corbin J. Basics of Qualitative Research Grounded Theory Procedures and Techniques. Newbury Park, CA: Sage; 1991.
   Google Scholar
• Miles MB, Huberman AM. Qualitative Data Analysis. Newbury Park, CA: Sage; 1994.
   Google Scholar
• Joseph H. A probation department treats heroin addicts. Fed Probat. 1973;37:35–39.
   Google Scholar
• Bahr SJ, Masters AL, Taylor BM. What works in substance abuse treatment programs for offenders. Prison J. 2012;92:155–174.
   Web of Science ®Google Scholar
• Leukefeld CG, Tims FM. Compulsory treatment of drug abuse: Research and clinical practice. NIDA research monograph, 86. Leukefeld, Carl G. (Ed); Tims, Frank M. (Ed). Rockville, MD, US: National Institute on Drug Abuse Compulsory treatment of drug abuse: Research and clinical practice; 1988.
   Google Scholar
• Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301:183–190.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Use Disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
   Google Scholar
• Csete J, Catania H. Methadone treatment providers' views of drug court policy and practice: a case study of New York state. Harm Reduct J. 2013;10:35–43.
   PubMed Web of Science ®Google Scholar
• Woody GE, Kane V, Lewis K, Thompson R. Premature deaths after discharge from methadone maintenance: a replication. J Addict Med. 2007;1:180–185.
   PubMed Web of Science ®Google Scholar
• Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102:1954–1959.
   PubMed Web of Science ®Google Scholar
• Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326:959–960.
   PubMed Web of Science ®Google Scholar
• Condelli WS, Fairbank JA, Dennis ML, Rachal JV. Cociane use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat. 1991;8:203–212.
   PubMed Web of Science ®Google Scholar
• Grella CE, Wugalter SE, Anglin MD. Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction. J Drug Issues. 1997;27:203–224.
   Web of Science ®Google Scholar
• DeMichele MT. Probation and parole's growing caseloads and workload allocation: Strategies for managerial decision making. Available at: https://www.appa-net.org/eweb/docs/appa/pubs/SMDM.pdf. Published 2007. Accessed October 15, 2015.
   Google Scholar
• Wicklund C. Assessment, treatment, and compliance. Recommendations to the community corrections field: From the national community corrections forum. Alexandria, VA: Institute for Law and Justice; 2008.
   Google Scholar